Compare AIRS & LFMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIRS | LFMD |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.4M | 218.1M |
| IPO Year | 2021 | 2012 |
| Metric | AIRS | LFMD |
|---|---|---|
| Price | $1.76 | $2.86 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $4.50 | ★ $8.13 |
| AVG Volume (30 Days) | ★ 825.3K | 777.5K |
| Earning Date | 11-06-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 141.67 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $151,818,000.00 | $12,468,578.00 |
| Revenue This Year | N/A | $7.00 |
| Revenue Next Year | $2.65 | $18.09 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 49.79 |
| 52 Week Low | $1.51 | $2.60 |
| 52 Week High | $12.00 | $7.32 |
| Indicator | AIRS | LFMD |
|---|---|---|
| Relative Strength Index (RSI) | 28.28 | 37.48 |
| Support Level | $1.51 | $2.66 |
| Resistance Level | $3.31 | $3.46 |
| Average True Range (ATR) | 0.16 | 0.17 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 0.00 | 6.11 |
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.